Education
About Us
Working with TipRanks
Follow Us
Allan Reine Insider Profile
4 Followers
Allan Reine, CFO at Palvella Therapeutics, holds 125.00K shares in Prime Medicine, Inc. (Ticker: PRME), holds 53.78K shares in Foghorn Therapeutics (Ticker: FHTX), holds ― shares in Palvella Therapeutics (Ticker: PVLA). Most recently, Allan Reine Bought ― shares of Prime Medicine, Inc. on May 22, 2025 for an estimated value of $146.25K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+103.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Allan Reine holds in companies
Most Profitable Insider Trade
The most profitable trade made by Allan Reine
Allan Reine's Trading History
Palvella Therapeutics
Aug 17, 2017
CFO
Informative Buy
313.35K
―
Foghorn Therapeutics
Aug 11, 2021
CFO
Uninformative Buy
100.04K
$263.00K
Prime Medicine, Inc.
May 22, 2025
CEO, Director
Informative Buy
146.25K
$460.00K
List of latest transactions for each holding click on a transaction to see Allan Reine's performance on stock
You May Also Like
Allan Reine insider profile FAQ
What is the percentage of profitable transactions made by Allan Reine?
The percentage of profitable transactions made by Allan Reine is 100%.
What is the average return per transaction made by Allan Reine?
The average return per transaction made by Allan Reine is 103.30%.
What stocks does Allan Reine hold?
Allan Reine holds: PVLA, FHTX, PRME stocks.
What was Allan Reine’s latest transaction?
Allan Reine latest transaction was an Informative Buy of $146.25K.
What was Allan Reine's most profitable transaction?
Allan Reine’s most profitable transaction was an Informative Buy of PRME stock on May 22, 2025. The return on the trade was 196.70%.
What is Allan Reine's role in Palvella Therapeutics?
Allan Reine's role in Palvella Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.